Gastrointestinal Infection Testing Market

Gastrointestinal Infection Testing Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 293

Gastrointestinal Infection Testing Market

To learn more about this report, request a free sample copy

Gastrointestinal Infection Testing Market Overview

The report is titled as ‘Gastrointestinal Infection Testing Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Gastrointestinal Infection Testing market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Gastrointestinal Infection Testing market is expected to grow with significant rate in the near future.

In 2020, global gastrointestinal infection testing market was valued at US$ XXX Mn and expected to grow significantly at a CAGR of XXX % over the forecast period

Gastrointestinal Infection Testing Introduction

Gastrointestinal infections can be understood as bacterial, viral, or parasitic infections inducing gastroenteritis comprising both the small intestine and the stomach. The signs and symptoms of these gastrointestinal infections comprise abdominal pain, vomiting, and diarrhea. The elderly, young children, and immuno-compromised patients are considered more prone and at highest risks for such severe complications and chronic disease. Factors such as lack of water supplies, poor sanitation, and soaring globalization of food transport systems all make them susceptible to the formation of enormous epidemics of food and waterborne outbreaks of gastrointestinal infections and disorders. The diagnosis and affirmation of these gastrointestinal infections is likely to be carried out by means of several laboratory tests and point-of-care tests.

Notably, gastrointestinal infections, particularly diarrheal diseases, are accountable for significant morbidity and mortality all across the world. The quick diagnosis and timely and appropriate treatment are for that reason necessary in these circumstances. The high prevalence of gastrointestinal infections among the population, worldwide, owing to poor eating habits and unhealthy diets, is primarily projected to thustr the market growth in the near future. In addition to that, the rapid growth in prevalence of diarrhea due to factors like unseemly sanitation facilities, inadequacy of appropriate medical facilities, and unhygienic behavior of people, particularly in emerging economies, is also estimated to hold a major role in accelerating the growth of the global gastrointestinal infection testing market in the coming years.

Growing incidence of gastrointestinal infections and digestive diseases worldwide owing to unhealthy food habits

Intestines are essentially a vital component of the digestive system. Aside from assisting assimilation and soaking up of foods, they also facilitate in building immunity. The intestinal microbiome is basically an intricate system comprising of an infinite number of microorganisms and bacteria that help in immersion of nutrients and yield energy, whilst safeguarding the human body from viruses and injurious bacteria. Having said that, swift improvement and modernization of lifestyle along with ill dietary habits have paved its way to an enormous change in the working of the intestinal system. In point of fact, a novel study contends that the freshly adapted dietary and sanitary habits is likely to have paved its way to a decline in the bacteria 'Prevotella copri', an ordinary human gut microbe that assists in digestion. The researchers and scientists freshly ascertained that there was a definite extent of reduction in the bacteria in the modern generation that could be accredited to industrialization, autoimmune and gastrointestinal disorders, conditions like allergies, and obesity. Lethargic lifestyle in an urban environment introduced in alterations in diet, which is moderately low in fibers and higher in fat content. It also paved its way to the establishment of new hygiene habits and the extensive usage of antibiotics and other medical products.

The scientists and investigators reckon that all these factors are likely to have endowed to distressing the fragile balance of the intestinal microbiome, which may cause digestive disorders. Notably, a regimen that is relatively low in fibers and high in trans and saturated fats is likely to affect intestinal flora formulation and reduce intestinal flora multiplicity, paving its way to gastrointestinal infection and digestive diseases, in accordance with the research issued in the World Journal of Gastroenterology. Thus, the soaring prevalence of gastrointestinal infections and digestive issues all around the world attributing to il dietary habits is likely to drive the growth of the global gastro intestinal infection testing market in the following years.

Gastrointestinal Infection Testing Market Segmentation

The global gastrointestinal infection testing market is segmented on the basis of product type, technique, test type, pathogenic group, end user, and region.

By Product Type

Reagent Kits

Sequencing Kits

Equipment

By Technique

Molecular Techniques

Nucleic acid amplification techniques

DNA sequencing and typing

Direct molecular probe techniques

Nucleic acid quantitation

Bacteriological Culture Technique

Biochemical Technique

Conventional Technique

Standard Plate Count

Membrane filters

Others

By Test Type

ELISA

Endoscopy

Biopsy

Colonoscopy

Sigmoidoscopy

X-Ray

Ultrasound

Others

By Pathogenic Group

Enterotoxigenic E. Coli (ETEC)

Enteroinvasive E. Coli (EIEC)

Verotoxin Producing E. Coli (EHEC)

Enteropathogenic E. Coli (EPEC)

By End User

Hospital Laboratories

Diagnostic Laboratories

Research Institutes

By Region

North America

Latin America

Asia Pacific

Europe

Middle East

Africa

Gastrointestinal Infection Testing Market Key Players

Some of the key participating players in global gastrointestinal infection testing market are:

Becton, Dickinson, and Company (BD)

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories Inc.

Luminex Corporation

Hoffmann-La Roche Ltd.

bioMérieux SA

Quidel Corporation

Illumina, Inc.

Seegene Inc

Genetic Signatures

Nanotek Inc

Hologic Inc

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of Gastrointestinal Infection Testing

Advantages of Gastrointestinal Infection Testing

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.


Summarized Info Details
Base Year: 2021 Forecast Period: 2022-2030
Key Geographies:
  • North America, Latin America, Europe, Asia Pacific, Middle East, and Africa
Market Segmentation:
  • The global gastrointestinal infection testing market is segmented on the basis of product type, technique, test type, pathogenic group, end user, and region
Key Players:

Becton, Dickinson, and Company (BD), Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Luminex Corporation, Hoffmann-La Roche Ltd., bioMérieux SA, Quidel Corporation, Illumina, Inc., Seegene Inc, Genetic Signatures, Nanotek Inc, and Hologic Inc

Key Dynamics:
  • Growing incidence of gastrointestinal infections and digestive diseases worldwide owing to unhealthy food habits, Soaring applications for technologically advanced molecular techniques for infection detection, and Increased expenditure on healthcare sector
Market Size: US$ 725.8 Mn in 2030 CAGR: XX%

To learn more about this report, request a free sample copy


Select License Type

Frequently Asked Questions

The global gastrointestinal infection testing market is forecasted to reach at a value of US$ 725.8 Mn at the end of year 2030

Growing incidence of gastrointestinal infections and digestive diseases worldwide owing to unhealthy food habits, Soaring applications for technologically advanced molecular techniques for infection detection, and Increased expenditure on healthcare sector

The global gastrointestinal infection testing market is segmented on the basis of product type, technique, test type, pathogenic group, end user, and region

Becton, Dickinson, and Company (BD), Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Luminex Corporation, Hoffmann-La Roche Ltd., bioMérieux SA, Quidel Corporation, Illumina, Inc., Seegene Inc, Genetic Signatures, Nanotek Inc, and Hologic Inc



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK